OA08720A - Activated RNase L as a maker for viral infections. - Google Patents

Activated RNase L as a maker for viral infections.

Info

Publication number
OA08720A
OA08720A OA59294A OA59294A OA08720A OA 08720 A OA08720 A OA 08720A OA 59294 A OA59294 A OA 59294A OA 59294 A OA59294 A OA 59294A OA 08720 A OA08720 A OA 08720A
Authority
OA
OAPI
Prior art keywords
pathway
rnase
aids
biochemical
inhibitor
Prior art date
Application number
OA59294A
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of OA08720A publication Critical patent/OA08720A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
OA59294A 1987-03-03 1988-03-03 Activated RNase L as a maker for viral infections. OA08720A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2137287A 1987-03-03 1987-03-03

Publications (1)

Publication Number Publication Date
OA08720A true OA08720A (en) 1989-03-31

Family

ID=21803819

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59294A OA08720A (en) 1987-03-03 1988-03-03 Activated RNase L as a maker for viral infections.

Country Status (20)

Country Link
EP (1) EP0285263B1 (ru)
JP (1) JPH0675520B2 (ru)
KR (1) KR880011593A (ru)
AT (1) ATE107964T1 (ru)
AU (1) AU618525B2 (ru)
CA (1) CA1337278C (ru)
DE (1) DE3850428T2 (ru)
DK (1) DK112888A (ru)
ES (1) ES2058252T3 (ru)
FI (1) FI880959A (ru)
IE (1) IE66831B1 (ru)
IL (1) IL85576A0 (ru)
MX (1) MX173802B (ru)
NO (1) NO880934L (ru)
NZ (1) NZ223721A (ru)
OA (1) OA08720A (ru)
PH (1) PH30882A (ru)
PT (1) PT86878B (ru)
RU (1) RU2049336C1 (ru)
ZA (1) ZA881471B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
EP0306347B1 (en) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnosis of double-stranded RNA deficiency states
AU724056B2 (en) * 1987-09-04 2000-09-14 Hem Research, Inc. Diagnosis and treatment of double stranded deficiency states
ATE103493T1 (de) * 1988-07-07 1994-04-15 Hem Pharma Corp Diagnose und behandlung chronischer ermuedungserscheinungen.
US5985565A (en) 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6080554A (en) * 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
WO2017193051A1 (en) * 2016-05-06 2017-11-09 The Trustees Of Princeton University Methods of monitoring rnase l activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
RU2049336C1 (ru) 1995-11-27
ES2058252T3 (es) 1994-11-01
KR880011593A (ko) 1988-10-29
MX173802B (es) 1994-03-29
NZ223721A (en) 1991-02-26
CA1337278C (en) 1995-10-10
NO880934L (no) 1988-09-05
ATE107964T1 (de) 1994-07-15
AU618525B2 (en) 1992-01-02
IL85576A0 (en) 1988-08-31
ZA881471B (en) 1988-12-28
PH30882A (en) 1997-12-23
AU1256388A (en) 1988-09-01
IE880587L (en) 1988-09-03
PT86878B (pt) 1992-05-29
DK112888A (da) 1988-09-04
EP0285263A2 (en) 1988-10-05
DK112888D0 (da) 1988-03-02
PT86878A (pt) 1988-04-01
NO880934D0 (no) 1988-03-02
DE3850428D1 (de) 1994-08-04
DE3850428T2 (de) 1994-11-24
IE66831B1 (en) 1996-02-07
FI880959A (fi) 1988-09-04
JPH0675520B2 (ja) 1994-09-28
JPS63309200A (ja) 1988-12-16
EP0285263B1 (en) 1994-06-29
FI880959A0 (fi) 1988-03-02
EP0285263A3 (en) 1990-04-18

Similar Documents

Publication Publication Date Title
AU6497694A (en) Method for selective inactivation of viral replication
PH30882A (en) Activated Rnase L as a maker for viral infections.
AU2022295A (en) Nucleic acid amplification with DNA-dependant RNA polymerase activity of RNA replicases
EP0944807A4 (en) CONNECTED BOW WITH COUNTERWEIGHT
NZ228645A (en) 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
WO1993017651A3 (de) Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung
AU590817B2 (en) Antiviral combinations
TW366339B (en) Derivatives of benzimidazolyl-cyclopentanediol, -cyclopentanol and -cyclopentenol, and pharmaceutical composition containing the same
ATE130760T1 (de) Synergistische wechselwirkung von interleukin-2 und doppelsträngiger rns.
MY106304A (en) Antiviral combinations and compounds therefor.
DK615788A (da) Nucleosidforbindelser til anvendelse mod virale infektioner
EP0340778A3 (en) Prodrugs of 2',3'- didehydro-2',3'-dideoxynucleosides
GB0016020D0 (en) New polyciclic xanthones and their use
WO1988007080A3 (en) Transgenic animal cells resistant to viral infection
EP0325462A3 (en) Anthelmintic milbemycin derivatives
JPS53135241A (en) Gain controller
ES2053601T3 (es) Agentes de biocontrol fundidos.
YU53790A (sh) Postupak za inhibiciju hiv korišćenjem sinergističkih kombinacija nukleozidnih derivata
JPS53139027A (en) Centrifugal type ignition timing adjusting system
JPS6431805A (en) Elimination of acrylonitrile in water or aqueous dispersion